BlackRock’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $457M | Buy |
|
|||||
|
2025
Q2 | $295M | Buy |
|
|||||
|
2025
Q1 | $88.9M | Sell |
|
|||||
|
2024
Q4 | $109M | Sell |
|
|||||
|
2024
Q3 | $131M | Buy |
|
|||||
|
2024
Q2 | $150M | Buy |
|
|||||
|
2024
Q1 | $174M | Buy |
|
|||||
|
2023
Q4 | $158M | Sell |
|
|||||
|
2023
Q3 | $123M | Sell |
|
|||||
|
2023
Q2 | $153M | Sell |
|
|||||
|
2023
Q1 | $127M | Buy |
|
|||||
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $153M | Buy |
|
|||||
|
2022
Q2 | $131M | Sell |
|
|||||
|
2022
Q1 | $143M | Buy |
|
|||||
|
2021
Q4 | $96.4M | Buy |
|
|||||
|
2021
Q3 | $126M | Buy |
|
|||||
|
2021
Q2 | $170M | Sell |
|
|||||
|
2021
Q1 | $157M | Buy |
|
|||||
|
2020
Q4 | $180M | Buy |
|
|||||
|
2020
Q3 | $96.5M | Buy |
|
|||||
|
2020
Q2 | $74.4M | Buy |
|
|||||
|
2020
Q1 | $26M | Sell |
|
|||||
|
2019
Q4 | $38.3M | Buy |
|
|||||
|
2019
Q3 | $25.2M | Buy |
|
|||||
|
2019
Q2 | $28M | Sell |
|
|||||
|
2019
Q1 | $21.4M | Sell |
|
|||||
|
2018
Q4 | $18.3M | Sell |
|
|||||
|
2018
Q3 | $31.5M | Buy |
|
|||||
|
2018
Q2 | $34.9M | Buy |
|
|||||
|
2018
Q1 | $26.2M | Buy |
|
|||||
|
2017
Q4 | $13M | Buy |
|
|||||
|
2017
Q3 | $59K | Buy |
|